SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004024
Filing Date
2018-05-04
Accepted
2018-05-04 16:03:24
Documents
61
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20180331x10q.htm 10-Q 1956992
2 EX-31.1 edit-20180331ex311e0e505.htm EX-31.1 19712
3 EX-31.2 edit-20180331ex3129ba097.htm EX-31.2 19272
4 EX-32.1 edit-20180331ex32115062f.htm EX-32.1 13535
  Complete submission text file 0001558370-18-004024.txt   6925152

Data Files

Seq Description Document Type Size
5 EX-101.INS edit-20180331.xml EX-101.INS 1485870
6 EX-101.SCH edit-20180331.xsd EX-101.SCH 52805
7 EX-101.CAL edit-20180331_cal.xml EX-101.CAL 42570
8 EX-101.DEF edit-20180331_def.xml EX-101.DEF 169264
9 EX-101.LAB edit-20180331_lab.xml EX-101.LAB 442548
10 EX-101.PRE edit-20180331_pre.xml EX-101.PRE 307962
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 18807850
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences